SAD is a common, clinically relevant feature of IPF. AX and Fres may serve as sensitive, non-invasive markers for disease monitoring and cardiovascular risk assessment. Further multicenter, longitudinal studies are needed to validate these findings and establish the role of oscillometry in routine clinical practice.
Kotsiou et al. (Wed,) studied this question.